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The efficacy of truncated exponential waveform shocks
using a cardioverter-defibrillator catheter with and with-
out a13.9 cml subcutaneous thoracic patch electrode
was examined in 10 pentobarbital-anesthetized dogs. The
cardioverter-defibrillator catheter was positionedthrough
the external jugular vein with the distal 4 cml shocking
electrode located in the right ventricular apex and the
8 cml proximal electrode located in the superior vena
cava. Four electrode configurations were tested: 1) distal
electrode (cathode) to proximal electrode and chest wall
patch (common anodes), 2) distal electrode (cathode) to
chest wall patch (anode), 3) distal electrode (cathode) to
proximal electrode (anode), and 4) chest wall patch
(cathode) to proximal electrode (anode). The lowest ran-
domized energy resulting in termination of alternating
current-induced ventricular fibrillation on four trials at
The automatic implantable defibrillator (AID) and its suc-
cessor , the automatic implantable cardioverter-defibrillator
(AleD, AID-B) have reduced the incidence of sudden car-
diac death in individuals previously identified to be at a high
risk for recurrent hypotensive ventricular tachycardia and
ventricular fibrillation (1,2 ). As it is currently configured,
the automatic implantable cardioverter-defibrillator uses either
a transvenous spring electrode paired with a patch electrode
(placed on the cardiac apex) or two patch electrodes applied
anteriorly and posteriorly on the epicardial surface of the
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that energy was 20.2, 21.3, 27.4 and > 40 J, respectively,
for configurations 1 through 4.
The energy requirements for configurations 1, 2 and
3 were significantly lower than for configuration 4 (p <
0.001). Additionally, configurations incorporating the
distal electrode and the patch electrode (configurations
1 and 2) were significantly better than the catheter alone
(configuration 3; p < 0.05). There was no significant
ditTerence between configurations 1 and 2.
In conclusion, the addition of a subcutaneous chest
wall electrode to the cardioverter-defibrillator catheter
significantly lowered energy requirements for defibril-
lation, suggesting that a nonthoracotomy approach for
the automatic implantable cardioverter-defibrillator is
feasible.
(J Am Coli CardioI1987;10:406-11)
right and left ventricles, respectively, for defibrillation (3).
The placement of one or more electrodes on the surface of
the heart necessitates entry into the thoracic cavity or me-
diastinum , with its attendant morbidity.
The purpose of the present study was to investigate the
feasibility of approaches to implantation of the defibrillating
lead system that do not require thoracotomy and, specifi-
cally , to determine whether a single defibrillating pulse de-
livered simultaneously through an orthogonal lead system,
consisting of a subcutaneou s chest wall electrode in com-
bination with an intravascular catheter , could reliably ter-
minate induced ventricular fibrillation within the output range
of the present automatic implantable cardioverter-defibril-
lator generator.
Methods
Experimental preparation. Ten mongrel dogs weigh-
ing 20.8 ± 2.6 kg (mean ± SD) were anesthetized with
pentobarbital 20 to 25 mg/kg intravenously and ventilated
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with a volume respirator using room air. The left femoral
artery was exposed and a 7F Cordis side arm introducer was
placed in the artery. A 6F bipolar electrode catheter was
passed through the introducer and positioned in the left
ventricular apex using fluoroscopy. This catheter was used
to apply alternating current (AC) for the induction of ven-
tricular fibrillation . A separate catheter in the left ventricle
was chosen for AC current delivery. because we wished to
examine separately the pathologic effects of the defibrillat-
ing shocks and AC current. The sheath side arm was used
to continuously monitor arterial pressure and sample arterial
blood every 30 minutes.
The respirator was adjusted to maintain the partial pres-
sure of oxygen (Po2) at > 80 mm Hg, the pH between 7.35
and 7.45 and the partial pressure of carbon dioxide (PC0 2)
between 25 and 45 mm Hg. An IIF implantable cardio-
verter-defi brillator catheter (Intec Systems) was passed un-
der fluoroscopic guidance through the right external jugular
vein, so that its tip was in the right ventricular apex. The
catheter had a 16 rnrrr' tip electrode used for pacing, a 4
em? titanium distal electrode located 4 mm from the tip and
an 8 crrr' titanium proximal electrode positioned in the su-
perior vena cava with an interelectrode distance of 10 ern
(Fig. I). For satisfactorycatheter position a pacing threshold
of less than 1.0 V was required. A 13.9 crrr' titanium patch
Figure 1. The IIF implantable cardioverter-defibrillatorcatheter
consists of a 16 mrrr' tip electrode for pacing, a 4 em? titanium
distal electrode located 4 mm from the tip and an 8 ern- titanium
proximal electrode with an interelectrode distance of 10ern.
Figure 2. The four electrode configurations tested for internal
defibrillation are shown. The external electrode in I, 2 and 4 is
the subcutaneous chest wall patch electrode .
electrode was placed subcutaneously on the left thorax over
the cardiac apex. Bipolar e1ectrograms from the catheter tip
to the distal electrode and between the shocking leads were
recorded on a TEAC R6l tape recorder and displayed on
an Electronics for Medicine VR6 oscilloscope. Cutaneous
electrodes were placed to record lead II of the surface elec-
trocardiogram (ECG).
Electrode configurations for defibrillation (Fig. 2).
Using the catheter and chest wall patch. four electrode con-
figurations for internal defibrillation were tested: I ) distal
catheter electrode (cathode) to the proximal catheter elec-
trode as a common anode with the chest wall patch; 2) distal
catheter electrode (cathode) to the chest wall patch (anode);
3) distal catheter electrode (cathode) to the proximal catheter
electrode (anode); and 4) chest wall patch (cathode) to the
proximal catheter electrode (anode).
Experimental protocol. Ventricular fibrillation was in-
duced with 120 Hz rectified alternating current applied to
the left ventricular bipolar electrode catheter at the minimal
current required. Ventricular fibrillation was allowed to pro-
ceed for 10 seconds before defibrillation was attempted us-
ing a truncated exponential waveform shock from an ex-
ternal cardioverter-defi brillator (Intec Systems) having fixed
energy outputs of 2 to 40 J in 2 J increments. If the internal
shock failed to terminate ventricular fibrillation. a transthor-
acic rescue shock was applied. A minimum of 2.5 minutes
elapsed between fibrillation events.
Impedance measurements were made for each shock by
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measuring pulse width using a digital pulse width meter
(lntec Systems) that detected the leading and trailing edges
of the shock. Impedance was then calculated from the ratio
of the measured pulse width at any given energy and the
measured pulse width determined with a shock at the same
energy level delivered into a 50 ohm test load. Impedance
was calculated for all energy levels tested, and mean imped-
ance was computed for each configuration.
Defibrillation testing was initiated with a 30 J attempt.
Energy levels for subsequent internal defibrillation attempts
were reduced in 4 J decrements or increased in 4 J incre-
ments until a series of successes ended with a failure or a
series of failures ended with a success. The lowest successful
energy was defined as the initial threshold and defibrillation
efficacy tables were determined by performing four trials at
that energy and at energy levels 4 and 8J above and 4 and
8J below that level. These five sets of energy levels for each
configuration were tested randomly so that each energy level
was tested four times. If necessary, further energy levels
were added and randomly tested until there were four suc-
cesses and four failures at a given energy level for each
electrode configuration. SIOO was defined as the lowest en-
ergy at which all four shocks and all higher energies tested
were successful. Suspected lead dislodgment (indicated by
a change in intracavitary electrode signals, difficulty in de-
fibrillation or unexpected increase in the pacing threshold)
was assessed by fluoroscopic observation and, if the lead
required repositioning, the entire series of defibrillation trials
was repeated.
At the completion ofthe experiment, each dog was killed,
using an intravenous potassium chloride overdose. The heart
and lungs were removed and examined and the hearts were
weighed. The endocardial and epicardial lesions produced
by the shocks and alternating current were quantitated using
planimetry (length x width).
Statistical analysis. Mean and standard deviations were
calculated for the initial threshold, S100, SIOO normalized for
body weight and S100 normalized for heart weight. These
values were compared using the Kruskal-Wallis test (4).
This statistical test is useful when comparing more than two
means for data with a nonparametric distribution. Mean
impedance values were compared using analysis of vari-
ance.
Results
Relation of the four lead configurations to energy re-
quirement for defibrillation. The mean initial threshold
and lowest energy at which all four shocks and all higher
energy levels tested were successful (S100) for configurations
1 (18.8 and 20.2 J, respectively) and 2 (16.3 and 21.3 J,
respectively) were significantly lower (p < 0.05) than for
configuration 3 (25.9 and 27.4 J) and configuration 4 (for
which both means were greater than 40 J). For configura-
tions 1,2 and 3, the initial threshold values were lower than
SIOO, but this difference only reached statistical significance
for configuration 2. Examining mean SIOO and correcting
for body weight revealed a mean energy of 0.97 J/kg for
configuration I, 1.02 J/kg for configuration 2 and 1.32 J/kg
for configuration 3. Correcting for heart weight revealed a
mean energy of 0.136 Jig for configuration I, 0.139 Jig for
configuration 2 and 0.183 Jig for configuration 3. Mean
values could not be accurately calculated for configuration
4, because the S4 energy level frequently exceeded our en-
ergy capabilities. The mean impedances calculated for the
four lead configurations were 48.7, 69.6, 59.5 and 71.1
ohms, respectively. The mean impedance for configuration
I was significantly lower than that for configuration 2, 3 or
4 (p < 0.05), the mean impedance for configuration 3 was
significantly lower than that for configurations 2 and 4 (p
< 0.05) and there was no significant difference between
configurations 2 and 4. The calculated impedance did not
predict the energy requirements for defibrillation within a
configuration or between configurations.
Myocardial damage. Gross inspection of the right ven-
tricle revealed white discoloration or hemorrhage, or both,
at the site of right ventricular endocardial catheter contact
in all cases. The left ventricular endocardium at the site of
alternating current application showed lesser discoloration.
The mean area, measured by planimetry, of the right ven-
tricular endocardial lesions was 308 mm? for the 10 dogs
and 8 mm? at the left ventricular site of alternating current
application. Examination of the lungs revealed atelectasis
in four dogs, with intraalveolar hemorrhage observed in
three dogs. No evidence of pulmonary embolism was seen
in any animal. The dogs received 98 ± 11 (mean ± SO)
internal defibrillation shocks over 7 to 8 hours.
Discussion
Development of the current implanted defibrillator
lead system. The ideal electrode lead system for implanted
defibrillator use would allow ease of implantation for both
the operator and the patient and provide a low reliable energy
requirement for defibrillation. Nearly IS years ago, Mi-
rowski and coworkers (5,6) employed a defibrillating lead
configuration that consisted of an electrode located at the
tip of a catheter in the right ventricular apex and a second
electrode located under the skin of the anterior chest wall.
With this system, energies of 30 to 50 J were successful in
defibrillating the heart in dogs. In 1971, Mirowski et al. (6)
modified the lead configuration and used a catheter with a
tip electrode in the right ventricular apex and a more prox-
imal electrode in the superior vena cava. Nine of 11 patients
undergoing coronary artery surgery had successful defibril-
lation with energies :sIS J (7). With a similar catheter
electrode, Schuder et al. (8) were able to perform defibril-
lation in dogs using 20 to 40 J (9).





Study of several other defibrillating lead configurations
in dogs (9) showed that the lowest energy requirements and
the most consistent thresholds were achieved with delivery
of the defibrillating pulse from the base to the apex of the
heart. An intravascular electrode in the superior vena cava
paired with an intrapericardial apical conforming electrode
was ultimately chosen for automatic implantable defibril-
lator clinical investigation in humans because it was nearly
as effective as the base-apex system and somewhat easier
to place (9). This lead system, however, requires entry into
the thorax or mediastinum for placement.
Nonthoracotomy approaches to internal defibrilla-
tion. Interest in a less invasive approach for internal defi-
brillation has resulted in recent human studies utilizing a
catheter alone. Winkle et al. (10) reported successful de-
fibrillation with 10 to 20 J in five of eight patients tested,
using a transvenous implantable cardioverter-defibrillator
catheter before installation of their permanent lead system.
Table 1. Comparison of Previously Reported Clinical Data and Experimental Animal Data for Internal Defibrillation Thresholds
Electrode Study
Combination Species DFf (1) Waveform Electrode Surface Area First Author & Ref.
Catheter with SVC Canine 20 to 40 Unidirectional Variable (264 to 1,056 rnrrr' Schuder (8)
electrode and rectangular proximal sleeve, 79.2 to
RVapical 237.6 mrrr' distal sleeve)
electrode
Canine 9 Truncated 250 mnr' cathode, 250 mm? Kallok (19)
exponential anode
60% tilt
Canine 25.9 Truncated 8 em? proximal spring, 4 Wetherbee (Present study)
exponential cnr' distal spring
60% tilt
Human 25 Truncated 8.5 crrr' proximal spring, Winkle (10)
exponential 4.3 em! distal spring
60% tilt
Human IS Truncated NS Mirowski (20)
exponential
SVC electrode with Canine 12 to 19 Unidirectional 188.5 mm? sleeve, 11.9 Schuder (21)
epicardial patch rectangular em? disk
Canine II Truncated 12 cnr' catheter, 12 ern? Deeb (22)
exponential patch
Canine 25 Truncated NS Mirowski (23)
exponential
Porcine 17 Truncated 12 crrr' catheter, 12 em? Deeb (22)
exponential patch
Human 25 Truncated 10 em? spring, 12 crrr' Winkle (24)
exponential patch
60% tilt
SVC electrode with Human 19.1 Truncated 6.5 crrr' patch, 13.9 or 27.9 Troup (3)
epicardial patch exponential em" patch
Two epicardial Canine 11.7 Truncated 12 em? patch, 12 em: patch Deeb (22)
patches exponential
Canine 3 to 5 Truncated NS Mirowski (20)
exponential
Porcine 15.8 Truncated 12 em? patch, 12 ern? patch Deeb (22)
exponential
Human 9.8 Truncated 13.9 cnr' patch, or 27.9 Troup (3)
exponential crrr' patch, or both
Catheter electrode Canine 5 to 15 Truncated NS (RV apical catheter Mirowski (20)
(SVC or RV exponential subcutaneous patch)
apex, or both) Canine 18.8 Truncated 8 em? SVC catheter Wetherbee (Present study)
with subcutaneous exponential cathode, 4 em? RV
or cutaneous 60% tilt catheter, 13.9 em? patch
electrode anode
Canine 15 to 24 Unidirectional 188.5 ern? SVC catheter, Schuder (21)
rectangular I 1.9 em" cutaneous disk
Human None
DFf = defiibrillation threshold; NS = not specified; RV = right ventricular; SVC = superior vena cava.
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Using the same catheter, we found defibrillation thresholds
ranging from 10 to 25 J in four patients (unpublished ob-
servations). It appears that defibrillation with an intravas-
cular catheter is feasible in some patients employing the
present automatic implantable cardioverter-defibrillator gen-
erator.
Attempts to reduce the energy required for defibrillation
have led to the investigation of other methods of energy
delivery. The concept of sequential shocks was first sug-
gested by Wiggers (11) in 1940 and applied to transthoracic
defirillation. Orthogonal sequential pulse delivery (in which
both temporal and spatial summation of pulses occurs) has
been reported (12-16) to decrease the energy requirements
for internal defibrillation when compared with a single pulse
delivered through an intravascular catheter. However, se-
quential pulse delivery is not adaptable to the current au-
tomatic implantable cardioverter-defibrillator generator.
Using a single orthogonal shock in this study, we ob-
served a statistically significant reduction in the defibrilla-
tion energy requirements using a subcutaneous chest wall
patch combined with a catheter electrode compared with the
catheter used alone. The addition of the subcutaneous patch
also resulted in a mean SIOO of <25 J that would allow
reproducible defibrillation at energies within the output ca-
pability of the current automatic implantable cardioverter-
defibrillator generator. Additionally, this lead system is
adaptable to the current device.
The cardiac damage seen at the site of the implanted
right ventricular endocardial electrode is of concern, but
is probably magnified by the great number of shocks given
over a short time period that would not be expected in
clinical use. However, previous animal data (17-19) utiliz-
ing defibrillating catheter electrodes and fewer shocks have
also shown some evidence of endocardial damage at the site
of the shocking electrode.
Relation of leadconfiguration to defibrillation thresh-
old. A comparison between reported clinical data and ex-
perimental animal data for internal defibrillation thresholds
of various electrode combinations is presented in Table 1
(3,8,10,19-24). Generally, similar thresholds have been
reported for a given lead configuration in human and canine
studies, suggesting that a lead system found effective in
canine trials might achieve similar results in clinical trials.
The lowest defibrillation thresholds are found with an elec-
trode system utilizing two epicardial patches, followed by
the superior vena cava spring-epicardial patch system, fol-
lowed by the defibrillating catheter (consisting of a superior
vena cava electrode-right ventricular apex electrode [3,25]).
The present study demonstrates a significant decrease in the
defibrillation threshold with a subcutaneous chest wall patch
in combination with the distal electrode of the implantable
cardioverter-defibrillator catheter as compared with the
threshold for the catheter used alone. In patients in whom
the catheter alone provides an inadequate safety margin for
defibrillation, the subcutaneous patch electrode could then
be added and defibrillation testing repeated. Only those pa-
tients with unacceptably high thresholds with the catheter-
subcutaneous patch system would require a thoracotomy for
the placement of epicardial patches.
Limitations of the study. The present study did not
examine all possible electrode configurations incorporating
the catheter and the patch. The selection of electrode con-
figurations was an attempt to extend prior observations (10)
using the catheter alone in which the distal catheter electrode
served as the cathode and the proximal catheter electrode
as the anode. We chose to leave the assignments for the
catheter electrodes unchanged while adding a second current
pathway that would drive current across the fibrillating ven-
tricles and therefore made the subcutaneous patch anodal.
This orthogonal system was then compared with each single
current pathway.
The present study is constrained to some extent by the
currently available electrodes. Optimal patch size, patch
location, catheter electrode surface area and interelectrode
distance require further evaluation, particularly when con-
sidering human application in view of the differences in
chest configuration between dogs and humans. The relative
motion of the heart and subcutaneous patch that could occur
during activity, heavy breathing or a seizure was not as-
sessed in this anesthetized canine preparation. Different
methods of defining the defibrillation threshold have been
reported (5-8). We have not derived a dose-response curve
from our data because this requires extrapolation between
measured data points.
Conclusions. In this acute anesthetized canine model,
use of a subcutaneous chest wall patch in combination with
the distal electrode of the implantable cardioverter-defibril-
lator catheter, with or without the proximal electrode, was
associated with significantly lower defibrillation require-
ments than those obtained with the catheter alone or with
the proximal electrode in combination with the patch. We
have shown that an approach to internal defibrillation not
requiring thoracotomy is feasible in dogs and can reliably
accomplish defibrillation within the range of energies avail-
able in the present automatic implantable cardioverter-de-
fibrillator generator. These data support trials of a similar
nonthoracotomy defibrillating lead system in humans.
We thank Stephanie Cavros for preparation of the manuscript.
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